Cargando…
Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
BACKGROUND: The Pfizer BioNTech COVID-19 vaccine was the first to receive emergency authorization and approval from the FDA. Therefore, it is preferred by most recipients; however, many people are concerned about the vaccine’s side effects. At the time of the study, December 2021, Palestine lacked a...
Autores principales: | Abukhalil, Abdallah Damin, Shatat, Sireen Sultan, Abushehadeh, Raya Riyad, Al-Shami, Ni’meh, Naseef, Hani A., Rabba, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814351/ https://www.ncbi.nlm.nih.gov/pubmed/36604613 http://dx.doi.org/10.1186/s12879-022-07974-3 |
Ejemplares similares
-
Evaluation of Self-Medication with Antibiotics in Primary Care Clinics in Palestine
por: Naseef, Hani, et al.
Publicado: (2022) -
Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2023) -
Vitamin D Deficiency Association with Comorbid Diseases in Palestine: “A Cross-Sectional Observation Study”
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2022) -
A racing heart post‐Pfizer/BioNTech BNT162b2
por: Teo, Hooi Khee, et al.
Publicado: (2022) -
Knowledge, attitudes, and practices about coronavirus disease (COVID-19) among Birzeit University students: a cross-sectional study
por: Naseef, Hani A., et al.
Publicado: (2021)